Association of IL-4RA single nucleotide polymorphisms, HLA-DR and HLA-DQ in children with Alternaria-sensitive moderate-severe asthma

Clinical and Molecular Allergy

Volumn 8, Issue , 2010, Pages

  Knutsen, Alan P ^a,b   Vijay, Hari M ^c   Kariuki, Barbara ^a,b   Santiago, Luis A ^a   Graff, Ralph ^a   Wofford, Jonathan D ^a   Shah, Maulik R ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c Environmental Health Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CD19 ANTIGEN; CD23 ANTIGEN; CD86 ANTIGEN; CORTICOSTEROID; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 4 RECEPTOR ALPHA; ISOLEUCINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; OMALIZUMAB; VALINE;

ADOLESCENT; ADULT; ALTERNARIA; ANTIGEN EXPRESSION; ARTICLE; ASPERGILLUS; ASTHMA; B LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLADOSPORIUM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HLA TYPING; HUMAN; HUMAN CELL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION;

EID: 77951175814     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-8-5     Document Type: Article

References (41)

1. Wenzel SE, Busse WW, . National Heart, Lung, and Blood Institute's Severe Asthma Research Program Severe asthma: lessons from the severe asthma research program. J Allergy Clin Immunology 2007, 119:12-21. National Heart, Lung, and Blood Institute's Severe Asthma Research Program.
2. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006, 27:615-626. 10.1183/09031936.06.00074705, 16507864.
3. Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004, 113:227-234. 10.1016/j.jaci.2003.11.023, 14767434.
4. Cantani A, Ciaschi V. Epidemiologogy of alternaria alternate allergy: a prospective study in 6840 Italian asthmatic children. Eur Rev Med Pharmacol Sci 2004, 8:289-294.
5. Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Clin Allergy Immunol 1999, 103:709-711.
6. Zuereik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F, . European Community Respiratory Health Survey Sensitization to airborne moulds and severity of asthma: cross-sectional study fro European Community respiratory health survey. BMJ 2002, 325:411-414. 10.1136/bmj.325.7361.411, 119432, 12193354, European Community Respiratory Health Survey.
7. O'Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med 2005, 5:4. 10.1186/1471-2466-5-4, 550663, 15720706.
8. Nolles G, Hoekstra MO, Schouten JP, Gerritsen J, Kauffman HF. Prevalence of immunoglobulin E for fungi in atopic children. Clin Exp Allergy 2001, 31:1564-1570. 10.1046/j.1365-2222.2001.01186.x, 11678856.
9. Stark PC, Burge HA, Ryan LM, Milton DK, Gold DR. Fungal levels in the home and lower respiratory tract illnesses in the first year of life. Am J Respir Crit Med 2003, 168:232-237.
10. Halonen M, Stern DA, Lohman C, Wright AL, Brown MA, Martinez FD. Two subphenotypes of childhood asthma that differ in maternal and paternal influences of asthma risk. Am J Respir Crit Care Med 1999, 160:564-570.
11. Downs SH, Mitakakis TZ, Marks GB, Car NG, Belousova EG, Leuppi JD. Clinical importance of Alternaria exposure in children. Am J Respir Crit Care Med 2001, 164:455-459.
12. Delfino RJ, Zeiger RS, Seltzer JM, Street DH, Matteucci RM, Anderson PR, Koutrakis P. The effect of outdoor fungal spore concentrations on daily asthma severity. Environ Health Perspect 1997, 05:622-635.
13. Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, Sternberg AL. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 1999, 104:775-785. 10.1016/S0091-6749(99)70287-3, 10518821.
14. Perzanowski MS, Sporik R, Squillace SP, Gelber LE, Call R, Carter M, Platts-Mills TA. Association of sensitization to Alternaria allergens with asthma among school-age children. J Allergy Clin Immunol 1998, 101:626-632. 10.1016/S0091-6749(98)70170-8, 9600499.
15. Peat JK, Tovey E, Mellis CM, Leeder SR, Woolcock AJ. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1993, 23:812-820. 10.1111/j.1365-2222.1993.tb00258.x, 10780887.
16. Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997, 155:1356-1361.
17. Dales RE, Cakmak S, Burnett RT, Judek S, Coates F, Brook JR. Influence of ambient fungal spores on emergency visits for asthma to a regional children's hospital. Am J Respir Crit Care Med 2000, 162:2087-2090.
18. Martinez FD. Progression of asthma from childhood to adolescence. Eur Respir Rev 1997, 40:8-10.
19. Targonski PV, Persky WW, Ramekrishan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995, 95:955-961. 10.1016/S0091-6749(95)70095-1, 7751516.
20. Black PN, Udy AA, Broide SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000, 55:501-504. 10.1034/j.1398-9995.2000.00293.x, 10843433.
21. Celenza A, Fothergill J, Kupek E, Shaw RJ. Thunderstorm associated asthma: a detailed analysis of environmental factors. BMJ 1996, 312:604-607. 2350378, 8595333.
22. Rosas I, McCartney HA, Payne RW, Calderón C, Lacey J, Chapela R, Ruiz-Velazco S. Analysis of the relationships between environmental factors (aeroallergens, air pollution, and weather) and asthma emergency admissions to a hospital in Mexico City. Allergy 1998, 53:394-401. 10.1111/j.1398-9995.1998.tb03911.x, 9574882.
23. Dales RE, Cakmak S, Judek S, Dann T, Coates F, Brook JR, Burnett RT. The role of fungal spores in thunderstorm asthma. Chest 2003, 123:745-750. 10.1378/chest.123.3.745, 12628873.
24. Pasqualotto A, Powell G, Niven R, Denning DW. Evaluation of the effect of antifungal therapy on severe asthma with fungal sensitization (SAFS) and allergic bronchopulmonary aspergillosis. Respirology 2009, 14:1121-1127. 10.1111/j.1440-1843.2009.01640.x, 19909460.
25. Bellone CJ, Chauhan B, Knutsen AP, Hutcheson PS, Slavin RG. MHC class II restriction of cloned T-cells reactive with the Aspergillus fumigatus allergen, Asp f1. J Allergy Clin Immunol 1995, 95:356.
26. Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M, Slavin RG, Bellone CJ. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000, 106:723-729. 10.1067/mai.2000.109913, 11031343.
27. Knutsen AP, Kariuki B, Santigo L, Hutcheson PS, Brusatti J, Slavin RG, Bellone CJ, Shah MR. HLA-DR, IL-4RA, and IL- 10: Genetic risk factors in allergic bronchopulmonary aspergillosis. Pediatr Asthma Allergy Immunol 2009, 21:185-190.
28. Knutsen AP, Kariuki B, Consolino JD, Warrier MR. IL-4 alpha chain receptor (IL-4RA) polymorphisms in allergic bronchopulmonary aspergillosis. Clin Mol Allergy 2006, 3:1-6.
29. Kauffman HF, Tomee JF, Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clinic Immunol 1193, 105:1185-2000.
30. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. A protease-activated pathway underlying Th cell type 2 activations and allergic lung disease. J Immunol 5911, 169:5904-2002.
31. Chatterjee R, Batra J, Das S, Sharma SK, Ghosh B. Genetic association of acidiic mammalian chitanse with atopic asthma and serum total IgE levels. J Allergy Clin Immunol 2008, 122:202-208. 10.1016/j.jaci.2008.04.030, 18602573.
32. Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF, Nicolae DL, Elias JA, Chupp GL. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008, 358:1682-1691. 10.1056/NEJMoa0708801, 2629486, 18403759.
33. Hershey GKK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. Association of atopy with a gain-of-function mutation in the interleukin-4 receptor a chain. N Engl J Med 1997, 37:1720-1725.
34. Kruse S, Japha T, Tedner M, Sparholt SH, Forster J, Kuehr J, Deichmann KA. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999, 96:365-377. 10.1046/j.1365-2567.1999.00705.x, 2326760, 10233717.
35. Ober C, Leavitt SA, Tsalenko A, Howard TD, Hoki DM, Daniel R, Newman DL, Wu X, Parry R, Lester LA, Solway J, Blumenthal M, King RA, Xu J, Meyers DA, Bleecker ER, Cox NJ. Variation in the interleukin-4 receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000, 66:517-526. 10.1086/302781, 1288105, 10677312.
36. Deichmann KA, Heinzmann A, Forster J, Dischinger S, Mehl C, Brueggenolte E, Hildebrandt F, Moseler M, Kuehr J. Linkage and allelic association of atopy and markers flanking the IL-4-receptor gene. Clin Exp Allergy 1998, 28:151-155. 10.1046/j.1365-2222.1998.00159.x, 9515586.
37. Mitsuyasu H, Izuhara K, Mao XQ, Gao PS, Arinobu Y, Enomoto T, Kawai M, Sasaki S, Dake Y, Hamasaki N, Shirakawa T, Hopkin JM. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998, 19:119-120. 10.1038/472, 9620765.
38. Rosa-Rosa L, Zimmermann N, Bernstein JA, Rothenberg ME, Khurana Hershey GK. The R576 IL-4 receptor alpha allele correlates with asthma severity. J Allergy Clin Immunol 1999, 104:1008-1014. 10.1016/S0091-6749(99)70082-5, 10550746.
39. Risma KA, Wang N, Andrews RP, Cunningham CM, Ericksen MB, Bernstein JA, Chakraborty R, Hershey GK. V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function. J Immunol 2002, 169:1604-1610.
40. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 2005, 115:747-754. 548315, 15711639.
41. Chen W, Ericksen MB, Hershey GKK. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants. J Allergy Clin Immunol 2004, 114:553-560. 10.1016/j.jaci.2004.04.044, 15356556.